Beyond the Hype: Deep Neural Networks Outperform Established Methods Using A ChEMBL Bioactivity Benchmark Set
Eelke Bart LenselinkiD, Niels ten Dijke, Brandon J. BongersiD, George PapadatosiD, Herman van VlijmeniD, Wojtek KowalczykiD, Adriaan P. IJzermaniD, Gerard J. P. van WesteniD
Abstract
The increase of publicly available bioactivity data in recent years has fueled and catalyzed research in chemogenomics, data mining, and modeling approaches. As a direct result, over the past few years a multitude of different methods have been reported and evaluated, such as target fishing, nearest neighbor similarity-based methods, and Quantitative Structure Activity Relationship (QSAR)-based protocols. However, such studies are typically conducted on different datasets, using different validation strategies, and different metrics.\n\nIn this study, different methods were compared using one single standardized dataset obtained from ChEMBL, which is made available to the public, using standardized metrics (BEDROC and Matthews Correlation Coefficient). Specifically, the performance of Naive Bayes, Random Forests, Support Vector Machines, Logistic Regression, and Deep Neural Networks was assessed using QSAR and proteochemometric (PCM) methods. All methods were validated using both a random split validation and a temporal validation, with the latter being a more realistic benchmark of expected prospective execution.\n\nDeep Neural Networks are the top performing classifiers, highlighting the added value of Deep Neural Networks over other more conventional methods. Moreover, the best method ( DNN_PCM) performed significantly better at almost one standard deviation higher than the mean performance. Furthermore, Multi task and PCM implementations were shown to improve performance over single task Deep Neural Networks. Conversely, target prediction performed almost two standard deviations under the mean performance. Random Forests, Support Vector Machines, and Logistic Regression performed around mean performance. Finally, using an ensemble of DNNs, alongside additional tuning, enhanced the relative performance by another 27% (compared with unoptimized DNN_PCM).\n\nHere, a standardized set to test and evaluate different machine learning algorithms in the context of multitask learning is offered by providing the data and the protocols.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 334
- FWCI
- 24.21
- Field percentile
- top 1%
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Transfer learning applied in predicting small molecule bioactivity
Li Tian, Hugh Hongkai Huang, … Junzhou Huang·bioRxiv·Jan 9, 2025
- Evaluation of network architecture and data augmentation methods for deep learning in chemogenomics
Benoît Playe, Véronique Stoven·Journal of CheminformaticsPeer-reviewed·Feb 10, 2020
- Establishing the foundations for a data-centric AI approach for virtual drug screening through a systematic assessment of the properties of chemical data
Allen Chong, Ser-Xian Phua, … Wilson Wen Bin Goh·bioRxiv·Mar 28, 2024
- Systematic Benchmarking of Kinase Bioactivity Models Across Splitting Strategies and Protein Representations
Joshua M. Abbott·bioRxiv·Apr 22, 2026
- Kinome-wide activity classification of small molecules by deep learning
Bryce K Allen, Nagi G Ayad, Stephan C Schürer·bioRxiv·Jan 4, 2019
- Deep Batch Active Learning for Drug Discovery
Michael Bailey, Saeed Moayedpour, … Sven Jäger·bioRxiv·Jul 26, 2023